Jasper Bos is Director with Merck Serono Ventures, the corporate venture capital fund of Merck Serono SA. Prior to joining Merck Serono SA, Dr. Bos served as Investment Manager at IFHA, a growth capital fund backed by Dutch institutional investors and Goldman Sachs. He was instrumental in the founding and capital raise of IFHA and negotiated and managed investments in emerging economies in the healthcare and insurance sectors. Before joining IFHA, he worked as Health Economics and Strategy Manager at the Netherlands Vaccine Institute. Dr. Bos holds a PhD. in Pharmacy from the University of Groningen, the Netherlands. He has published over 30 articles on vaccines, public health and health economics.
Health economics